What did you think it would look like...millions of dollars in the bank? They just released the pilots in September last year so that's what I'm expecting to see results on near term:
The Q was great to me. Most pinkies have gazillion notes and gazillion shares and no business.
Here the remaining notes are tiny the OS is less than 400M and have an actual med product with FDA approved tech. If this was a VC backed private company it would be valued over $200 million. It is undervalued even at $0.25 now.
So I don't see any problem at all and it is severely undervalued.
The only thing that is killing this stock is the company is not giving updates. Being an OTC stcok, it requires regular updates to keep investors hopeful and invested. If they give one update each month this will go to a quarter easy.
News 
Market Data 
Discover 
